Zacks Investment Research Lowers Hanger (HNGR) to Hold
Zacks Investment Research lowered shares of Hanger (OTCMKTS:HNGR) from a buy rating to a hold rating in a research note issued to investors on Friday morning.
According to Zacks, “Hanger, Inc. delivers orthotic and prosthetic patient care, and distributes O&P products and rehabilitative solutions. The company’s products & services segment provides Hanger distributes branded and private label O&P devices, products and components and provides rehabilitative solutions. Hanger Inc., formerly known as Hanger Orthoped, is based in AUSTIN, Texas. “
Other equities analysts have also issued research reports about the stock. ValuEngine lowered shares of Hanger from a buy rating to a hold rating in a report on Monday, August 13th. TheStreet lowered shares of Hanger from a c rating to a d rating in a report on Wednesday, October 31st.
Hanger (OTCMKTS:HNGR) last issued its quarterly earnings results on Thursday, November 8th. The healthcare company reported $0.22 EPS for the quarter, topping the Zacks’ consensus estimate of $0.21 by $0.01. The company had revenue of $262.95 million during the quarter, compared to the consensus estimate of $260.07 million.
In other news, SVP Thomas E. Hartman sold 6,000 shares of the stock in a transaction on Tuesday, November 13th. The shares were sold at an average price of $19.89, for a total value of $119,340.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.36% of the stock is owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in the stock. Marshall Wace North America L.P. bought a new position in shares of Hanger during the 3rd quarter valued at $1,629,000. Marshall Wace LLP bought a new position in shares of Hanger during the 3rd quarter valued at $6,487,000. Ashford Capital Management Inc. bought a new position in shares of Hanger during the 3rd quarter valued at $1,042,000. Point72 Asset Management L.P. bought a new position in shares of Hanger during the 3rd quarter valued at $9,894,000. Finally, Prosight Management LP bought a new position in shares of Hanger during the 3rd quarter valued at $24,988,000. 3.61% of the stock is currently owned by institutional investors.
Hanger Company Profile
Hanger, Inc provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services.
Featured Article: What are trading strategies for the 52-week high/low?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hanger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanger and related companies with MarketBeat.com's FREE daily email newsletter.